semaglutide age approval A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Once-Weekly Semaglutide in Adolescents with

To control for multiple comparisons, the BenjaminiHochberg method was used to adjust the p values, and proteins with a false discovery rate (FDR) less than 0.05 were considered significant for further analysis

UPDATE 3/17/25: EllieMD has removed semaglutide from the name of its semaglutide sublingual drops and now refers to the product as GLP-1 sublingual drops

Medical Supervision and Monitoring Guidelines If you are taking testosterone and wish to start semaglutide or another GLP-1 therapy, inform your prescribing physician of your complete medication and supplement list

And and least in those who stay on the treatment forever So what happens when you discontinue the drugs